State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, The Affiliated Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, School of Life Sciences, Nanjing University, Nanjing, China.
Immunology. 2020 Aug;160(4):345-356. doi: 10.1111/imm.13196. Epub 2020 Apr 29.
Macrophages are particularly abundant and play an important role throughout the tumor progression process, namely, tumor-associated macrophages (TAM) in the tumor microenvironment. TAM can be polarized to disparate functional phenotypes, the M1 and M2 macrophages. M1-like type macrophages are defined as pro-inflammatory cells involved in killing cancer cells, while M2-like type cells can specially promote tumor growth and metastasis, tissue remodeling and immunosuppression. In this study, we first found that integrin β3 was highly expressed on the surface of TAM, both in vivo and in vitro, that displayed the M2-like characteristics. Under intervention of CYC or triptolide, the integrin β3 inhibitors, the M2 polarization of TAM could be inhibited. Moreover, in the cell model of M2 polarization, either blockade or knockout/knockdown of integrin β3 could also suppress macrophage M2 polarization, which suggested that the M2 polarization was dependent on integrin β3. Using knockdown of peroxisome proliferator-activated receptor-γ (PPARγ), an M2 regulator, we found that expression and activation of PPARγ participated in M2 polarization that was mediated by integrin β3. Finally, to verify the activity of integrin β3 inhibitors on TAM in vivo, 4T1 tumor-bearing mice were treated with CYC or triptolide; in response, the M1/M2 ratio of TAM was up-regulated, while the infiltration of total lymphocytes into tumor tissue was not altered. In general, our study found a connection between integrin β3 and macrophage polarization, which provides a strategy for facilitating M2 to M1 repolarization and reconstructing the tumor immune microenvironment.
巨噬细胞在肿瘤进展过程中特别丰富,并发挥着重要作用,即在肿瘤微环境中的肿瘤相关巨噬细胞(TAM)。TAM 可以极化为不同的功能表型,即 M1 和 M2 巨噬细胞。M1 样型巨噬细胞被定义为参与杀伤癌细胞的促炎细胞,而 M2 样型细胞可以专门促进肿瘤生长和转移、组织重塑和免疫抑制。在本研究中,我们首先发现整合素β3在体内和体外 TAM 的表面高度表达,表现出 M2 样特征。在整合素β3 抑制剂 CYC 或雷公藤内酯醇的干预下,TAM 的 M2 极化可被抑制。此外,在 M2 极化的细胞模型中,整合素β3 的阻断或敲除/敲低也可抑制巨噬细胞 M2 极化,这表明 M2 极化依赖于整合素β3。利用过氧化物酶体增殖物激活受体-γ(PPARγ)的敲低,M2 调节剂,我们发现 PPARγ 的表达和激活参与了由整合素β3介导的 M2 极化。最后,为了验证整合素β3 抑制剂在体内对 TAM 的活性,我们用 CYC 或雷公藤内酯醇处理 4T1 荷瘤小鼠;结果,TAM 的 M1/M2 比值上调,而总淋巴细胞浸润肿瘤组织的情况没有改变。总的来说,我们的研究发现了整合素β3 与巨噬细胞极化之间的联系,这为促进 M2 向 M1 再极化和重构肿瘤免疫微环境提供了一种策略。